Nagase & Co., Ltd. · TSE:8012

Nagase & — FY2025 Earnings Presentation

58 slides from Nagase &'s earnings presentation, May 15, 2026

  1. Slide 1: 2025年度 決算説明会資料

    2025 A REA RE RANSH Gesa—k:8012) 20265A7H BR A\NAGASE Delivering next. (HRARR LEB ZICKSSLCUT—Yavy) RREREAAH CRAMER ROLE COSMET. CITKSALSHRUUELET. ENC 2025FE ARRAS SE CURESES.

  2. Slide 2: LIVIF FHV

    LIVIF 4 FHV PRBS AVS ARALECE CORB EER. Pi PRBOMMIL SIU MBE SY APM IBLAVELLEICAPICHESL NB CAS <i, PORT FF ROICRMESERLIRAHENVELE., ELABAIRERE.Opptacal. SAAR J Prinova)l—Tidis, Solutions BRORAR AMG ONutritionBROMEHBECLS, PP TLTYIAONS RHEL ANE SAR ORES BE IER, BIB, 1 IEL RABUROBABIEBIS. © {SHIRE Cle, PE

  3. Slide 3: NAGASEODSV7IXVRERUAK< BIRR

    NAGASEODSV7IXVRERUAK< BIRR POABK IK — a 202552 O8ira 20267 Omir eIXUb ey [SUSAR ERRRARDORD, | A |SESRSLORRRRREERAOT 2) Ay SAKE CATRALL HAL TEL Ciiial waevet ALES | XE Bae CA Vm: PCA ATARI py, /ARRSICTRBIRAS, XEVRBESIAAR | sak | PESHE REO. SACRA | ~S |SORMRCAREBIGENS. PHISH | OS tera. PEK RER, BF LAE

  4. Slide 4: 目次

    EUR @ 202548 HARARE RU 202658 iB RIEL P6~25 BRP SHBICOWT P27~52 <SSta> ¥ BRIAZMOHMERRLEREOSRICIT ES Y SHOES ¥ ERED 5S OHMS Y 20217 EB ~2025FEOTERGIVYVIIY POS ¥ Prinova7 )L-FOB#RE % 2025 RLY, PrinovaFV—FICS Case RAR RO -REBROKDE-MRELTHVET. 20245 ERMC DCE SBREIC LS MRA RRROMIECQVET. *K SUSILBVEFSHOAHE

  5. Slide 5: 2025年度 決算概況 目次

    202578 HARRARE RO 20267 161 BL B Sainasthe P6é PTE so LAF RS P7 BE CTX Ub alse LAPSE QHALER P8 BE CIXUE RIBAS QI P9 BeTXUMER P10~P14 B TEMEFAHRR P15~P17 @ Prinova7/L—TF NutritionBROKWR P18 BS CRaH Rx P19 BBtv yy1-70-st8eS P20 BePXUERSIOOWT P21 @ 202658 BHA REL P22~P24 BHRDEETRAR P25 AXNAGASE | Deliv

  6. Slide 6: 連結業績概要

    - — o = Rimes > TLESLUSRBUACSW CHAREBE EM. > FEAL B RA, PREBOMEIC LSARUBRCS 188s. WRC ME. > EBSerlatldiges. A, MBSRORMICOD SRAM. > SEAMDA ESI AIRES. 20207 RICBURERELEAH CONS ZABROMMIN LBC KS BIBI (HA 2 THF) Sst LlE—A BOON ASEELS (491 HFS) PIAA Mass S Tole (3 SF) SERYIAATECEIC LS. (8) af ERGEL ; 2024

  7. Slide 7: 売上総利益・営業利益の増減

    PREM Al SoC KS Fl at > RIAA. EICFAL I 1 -FOARERE OTA TAT YIZOBELKS OMS (MULES) ICLS. > BONER. KIN COPrinova L—IO BHM A, T—-S Fett, PEP COG AEC IRA ERIC LS. BIA eot5e LAO FURE (5) BITC LAA AEO Hae RIIAR (fF) 2,000 1,100 Sit 1,876 on Ait 1,001 1,800 Sit 1,733 3594 1,001 1,000 att 190? aitoor “ise a 18

  8. Slide 8: Re LAIXVb a SsCE MFR HALRB

    Re LAIXVb a SsCE MFR 2 HALRB > REtLRISW2 2 OSE. EL UT 1 PHRERMO BRA ECUAAZSO RMS, BF LAE PEAREMTAEICLS. > BUSseltH1 22 AOI. 4 ARBICSIF S PrinovaT L—TORERO BUR, FAI 14 —YORBRRBICMA, BF-LRVE ISIS FHARTLTYIZOREL MNS HO MTA MSIC ES. > LIXVEAICILECUT 1 RRM DRY LA, RRS BF LHL —OMPR. (FMIST X MBERIC THEA)

  9. Slide 9: Re VAIXVEAMBR Fle HAL

    Re VAIXVEAMBR Fle 2 HAL > AEALIELLHT SRPOMES, BF-L4¥ OHA OMTABICLS. > Busse ki 7 7 OR. Prinovay L—FORBAAS| Be (1 318A) OSL, NutritionBROMAA CHEE, TALI 1 -IORBBEO AIO—BIRT SICLS. > ZO ith Set dees. FIC IEE ROA DD SBA BASIC LS. QBERO RAID D S BRON : 2024 SBR 3 512), 202557 RHA SHEAGR) POA ICSiR Lat L)

  10. Slide 10: セグメント別業績

    MRM CAIXUE BT HEBER > ToLRAASSEICLL FORBICKY, BORE A. + EAM AO RA RRSTIE IN. + RARAOMTTILRY. BBA RARER ICLS. > BRAS -REBAS MYO, at. (fF) 1Q re} 3Q 4Q Rt LS FY25 380 381 391 382 1,536 FY24 405 388 372 370 1,537 SGA A24 A6 18 12 Al FoLMAlR FY25 77 80. 82 81 322 FY24 88 81 79 75. 325 SSiRGA A10 Al 3 6

  11. Slide 11: セグメント別業績

    PNA COIXVUb BER DLA > SCERARELEICO FORAICAY . Hii. + OAS ER: BTS AIT BARTCICE UC, BID. A. FOS PhSYIARBIC AY ASL. + PHILO WALA M—AZ- LAAN TORRE AN > Eeetlieltoc LH AMOWMeE LT, Heh. 1Q 2Q 3Q RLS FY25 502 526 512 FY24 535 546 528 Sa A32 A20. Al6 FOR = FY25 65 69 69 FY24 65 65 67 SRA to} 3 1 <#RER> FY25

  12. Slide 12: セグメント別業績

    BF IRE CIXUEBR BF LR — > SCERFREILEICLA FORAICKY . 1B. + SEPA OARS CHAN. + FALTATYIZOREL MA AAEO PRTC AIS AN. E/N IV RRBS IIT DUREAICHES LEA, AL HAIBIIT SICH E HEC LICKS. + Pac Tech7JL—FIsetiCHES. ILINNVED TRO TAMIA, NU CUI SEY ER BBICES. > Eeplatltzs LMA MOMMERIT, Me. (fF) 1Q re} 3Q 4Q Rt LS FY25 4

  13. Slide 13: セグメント別業績

    | EeUT« PIXUMER ELUF 4 > SEERFRELEICOL RORBIC AY , Satie + TLBMROWLDE HH SHO Herel tao. + ASME BEMLALROMEEM AER MOAR LD. > BAA STE LA AMO RY ELIT, iat. Cie) 1Q 2Q 3Q 4Q Rta Le FY25 305 332 335 329 1,302 FY24 321 338 343. 317 1,320 iB A115 A6 A8 12 A18 so LeRle = FY25 37 40 39 41 159 FY24 40. 43 43.

  14. Slide 14: セグメント別業績

    LIXVUE BER ESRB > SERFS EICLA FORAIC KY, Hak. + RA BERR OR CISA + Prinova7/V—-FICSIFSRRRMOMTBILY—TYbVIPRAC KYIEM. + FHVI1—FSMREENE. GH MRM OMTSAMH ED, REM OMSICHITS MM GRSICKS. > Sra teat. TLMMMOMMICMA, FALI1 FICS SRA AH O—SBRT . PrinovaF /L—F OME (CHESIC KS. (FQ) 1Q 2Q 3Q 4Q Rt TLS FY25 768 751 760

  15. Slide 15: セグメント別業績

    ESREFSARR —-TARTATYIAZ- > Sc LROPIR LICL, RORBRRIC AY HBS. + BRET RAS BRO ARTES. HSN. E/ V4 RES AITHREA—75, AIS AIF RICKS + DaAbUU MORRIS KE, = BREOB REC LURE RSS, MRA AR. > Betlesitoe LM AAOMMICKY Seth. —b. AAMRRSO RSA SM. 202554A 1A CHAERRRET AI 1—-SD SBE. zl FY25 66 66 70. FY24 66 64 66 tasenas o

  16. Slide 16: セグメント別業績

    ESRIESSUMR —-THRI1—-9- > Sc RBPIRISEICL, RORBERIC AY, HBS. + RRMA SARE. MBNA) LEA, MER MRICLS + BHR O ike ta. BOAT ORY LIA, BAIT RE DAA RIC KU BI. > Berle toe LMR AOMMICK es. RU AT LANA ICA A SO. > ONAFHRA EAA BAO ABR TICK aD. GRARAR: BORACAY POI) K202554 A ANCHALIATY IAN MAIL EREREBE. 1Q 2Q 3Q s hy

  17. Slide 17: Prinova

    EBREFSHBR —Prinova7jp—TF- > FEARS EICLL FORBARICKY 1888. + BMRMOMTLY—TybVIPwACKVIBM. + BUGSAMAICHES. SolutionsBRICHIFS TOY Ab Sy DAKE, NutritionBxOWF tI KSMUREREO AR. > Berlei toe LMA ROMMICA) at. (MASSE 3st Lewes) 1Q 2Q 3Q 4Q TLE FY25 539 530 514 FY24 504 537 488 ee rore | brett 34 A6 25 FLA A so L

  18. Slide 18: Prinova Nutrition事業

    PrinovaZJL—ZF NutritionB#oOuws > 2025FRISAA HORE PRE LEO RELAIS TL. FIRS ANIC HEI. > 2026FRldby FIT RRC SREY. RAS BIT. Nutrition Ouse ~USDEA Bbc tS MERE 25.0 20.0 eS me 1s0 _AA AR ORE LE 100 ‘RNBE/9IS1F1- ORG 5.0 “SUELEOREUL/ Bat iOM SNE 0.0 5.0 a, “10.0 IAA IED BSS EEE es BHT -15.0 20.0 — fesse USD

  19. Slide 19: 連結貸借対照表

    ite A fa RK >» SACHEMHOPIP BRULEE, FALY—-ILPTIW—TD), FHRLITP FIAT I YIZOWEIC HE). BUF ARS A (tF3) 202543A# 2026F3AA EGR Eo RAE 5,601 5,663 61 (RERURE) 663 455 A207 (acBMITHE) 3,112 3,214 101 (AREDEE) 1,662 1,775 113 Bese 2,480 3,052 571 FHRY-ILPTW-F.FHRIAPTIAT AYIA (Fa MESS) 720 875 155 8,081 8,715

  20. Slide 20: キャッシュフロー

    BRtvyy1-IO—-Htes > BCFIS4 6 5BAOFVYLAP Ib. FALY—-ILP TIF, FALITP T/A AY IZOMESIC LS. > MICFIA253 GF AOF VY LAP Ih MRRAOR TC SEY RAREST O A, ACHAOMSS AOMARORMWSICLS. > RERORRAS L205 EARS. AXNAGASE | Delivering next. (figF) 20245 202558 BSSawICkStyyya-IoO- (Bie Sa AO BAA ES) (Ae BAERS) GERAAOISM) (ZOt

  21. Slide 21: 組織体制について

    CIXVEREICDWT > BER -hIFZUAOAHMCCR BRE OMURICE BAC. SLT XUREZLTX IEA Bilio CUCL URED EA OB ARC SMES BS EE SIC, ROICE BHC LES SHEL, BAERS ERISA ORRERVET. WLAIXUE See Me7XVb See =—— | were | BRE | Sere mits Bexar | FO-IWPHTIE eeuz, | BD earn: | | ee Bz. | TVArFO=IAA TLobo= 42 a TVArO=IA Tab — | Fete me

  22. Slide 22: 2026年度 連結業績予想

    20267 iBHisR ia BBL TLASLUSRBUMICH CHARA SA. TOL AFA. HOM BRARY ORMRMNHS—A, BACB REEB. MA CHAREKE. Bel alta. MRICAIKAMTRACAT 1 ABSSIC LUBA MSS SA, Bia CBR CBRN BAOWIICLS. SAR ROWS SEA BHA BLERE XRBERORAICOD SBR: 202538 W3ikAGA). 202658 408A (8) vvvy (fF) 20255 20265 . ae Se aL ‘Seta TT aa 9,727 10,0

  23. Slide 23: 2026年度 セグメント別予想

    2026FE tIXVbSISR BL > SUTXVECE BRA Lia. 5o LAOS S—, RICAIFEAATRA PAT 1 ABSICHS BAEMSICLS. (8) 2025FE 20265 mah at whe 4,905 4,955 49 101% * Bist BFA OMMSARTTICS CHE PRE E. TOY IhSYIAZORBICK Te _LA AES 757 776 18 102% U Rigs % aE IBDOLAHED VFUPIL <PRE> 15.4% 15.7% O.2ppt - Ree ee RO Re IBECUT 1) nn a

  24. Slide 24: 2026年度 セグメント別予想

    20267R $RRiafatO Rik RL > FARTLTYIZ: ToL P RS LGR. BET RAS REO ARSC, ALRITE SE SCE SICKS. BSF as Saad. OLAS ST PRICIER BES LFA ERAS CRABB AMBIT SCEICLS. 2026545 1AM CRW ES LE RRA HE > tHRI1—-49: ToL Plag Lait. Bian: Stim eM RTC SaaS. —A. RAE MOREE, SROMMAAICS IT S RO MLE RAR BRON —T7 1S RREROROB AIM

  25. Slide 25: 配当

    REIT > 20287 RECO37FIC HC, MAURICE BALL, BOAO CHREIICAT (BIND FIRE EPS 37F30%MR) > 20267 EO 1 RAE UES ISH 3A. AAR 4 OSM? TAS PEC] THRE RL) > 20267 4A 1 AN CHADS! (408i) SSE (ABP) %) 40,000 —F—4ee BOHR PETA 105.4 110.0 00.0 35,000 90.¢ 30,000 80.0 25,000 70. 20,000 Do aa 15,000 40.0 10,000 6,006 6,79

  26. Slide 26: Walk the Talk 2028

    aA Se Walk the Talk 2028 A\NAGASE | Delivering next.

  27. Slide 27: トップメッセージ

    b> hyTxXyk— COSTA BU ERBMEIC WS CS SHANE BHEREBRISED MHORORMLCREOA CE SEE OMB ZED TEELE GRCUCRRE HE SA ICKECE KGIERR FSECEMCEELE FATE SRO CBRN SIERRA RLLITE v AFELU RT SPREE HAEREOR {EAS SICBRSCEERRNICESA VIEUAD RREBL MRCRERRE ERMIIAOBCL APEREINICTASAS SHEE HERO 5D S3RE2VYbKACRBLAT TORRICAITT BAMHBO

  28. Slide 28: Walk the Talk 2028 構成

    > Bx 1. BURA Ste ACE 2.00 FR RY 2. PHASE Walk the Talk 2028 AXNAGASE | Delivering next. 28 BRICQUET. KG Id, A PHS EBACE 2.00HRUIRY. SL CAT PHS ate CAS TUNES kT.

  29. Slide 29: ACE 2.0 の総括

    > AUPHHA@ Ss ACE 2.0 BAAS ACE 2.0 Cl, RIES ALOPRALOBS HIT, IN2S EER ORSECRRICMIFEN TUR RY REIT L, “BOIER’” OHEEZ RE WWarsiaO = LRALORS O NASH - SHZHEDIER O SAMECHAMEOIER + SHORE) BCRRERDORIE HRTF EUT AVIV RORRE 435/JEVBIROEL SULT HE O BrBRoOmt . *FO-NUP—yavic ko BEBAOUA O HBEDIEK + WER OPETALC RTE R

  30. Slide 30: 8.0 7.7 6.6 6.4 5.9 5.9 2 350 333 4 306 300 3 250

    550 9 8.0 7.7 500 8 6.6 6.4 7 450 447 5.9 5.9 6 400 390 5 352 350 333 4 306 300 3 250 2 219 200 1 150 0 2020年度 2021年度 2022年度 2023年度 2024年度 2025年度

  31. Slide 31: サステナビリティKPI

    .=F 7 = a5 > eee Uae KPI FATFTEUT 1 OPECL CHITEIEME BEDE KE, ZEOREOWEOED 3 TOMBKPISHE BRL, MAD SELLELE Bw OJFUBAR A-RVII—-KSIL | SCOPE1, 2H (2013EEEL) 37% LHe 32m(49.2%) {#8 (BA)IUT-DRXUEG—-AT 60LE 32k (61.7) LYF—-DAYE | (PIP) LU F—-D XUN ANAK 100% 32m (100%) KPI KPI 202078 | 202551 ple eres 18.3% ,

  32. Slide 32: ACE 2.0 振り返り

    P ACE 2.0 “HO3ER” #RUIRY BR—hI4 UA A SRA 5 REMI CSB SRE (SBA, DR, STD UT LUA)AOI Y—ZORS, FRESSZOBRE - PORERT, ZOKRSICKUMAHZBL, FI—-PRtHe BRL, PFS zaMbLELE Ware ORs ERALORS O UNRRSE -HEDIER O SAMEACHAMEOIER + TUR IK, SID ZICH SSR REE, + FMBEREREL, BREE IBERI?—VHEMRB, SachemtOPIT BH + PFUPUT 4 ORBLE A

  33. Slide 33: ET TAO Ew

    (S48) ET TAO Ew EMA, I—R. SA DUA LU AD3 DSCREN CRATE EF = 2A TIV—TF OBSERBE = SACL, BASHIR & ak LEU RO < EHEEL RUZ a 28 Eg i] CEATRO SSL FIR EA] SORA EF IKE 491 SAINI ADS 424 375 334 a = ese 186 150 ins 190 202 244 250 207 ” 75 70 225 238 256 159 176 178 137 163 175 202458 20257 RR 202672 REL 202472

  34. Slide 34: [Sea0)

    [Sea0) OES THI iE WR EPEC LEE CHET IU ERE RT EO RIAD ERR, EXS|DS (HGR, RE HL, RAR S EELE NER WH BRT SHOE RRAD LOB DRX “BIBICRMT TY EAE SATO RIDDLE OLA MEERA 2 IRE BAUAKPYPLELIUYT, REM RADE NEO SETHE E 3. ARIE PII IIe SED ADE [BRT SHOBRIRA HONIRA RURIRA, MRA OGRE) 24: AA 20215 202248 202358 202458 20

  35. Slide 35: Walk the Talk 2028

    > snchHAeeetst iy Walk the Talk 2028 CIAD SAAN pNDNM COZSHACRALEAWNCES ACE 2.0 CRRUMA CS EMR S BHbe tScHc, EOKORRICBITERMTESBES BITS CECT EQNIIERRICRITLTWC EWS REDS Walk the Talk(@3217) ep RS HH BOBZMCWELRST AXNAGASE | Delivering next. Ar PHAR Sati, Walk the Talk 2028ICDUVTCEHEALET. KF. ADSBUICIITEE

  36. Slide 36: NAGASEの強み

    P NAGASENSVEWS VOUP IVE TC, BRRCHRO RES REL POX JETER IOIDIVE—-TYTICRRMIS NAGASE AXNAGASE | Delivering next. CBE 5IKNAGASENSVEWNBCT. CMUELFRCUT, VTUP IVE T, BERCMHAO RAS AERLIOE | ETHER IOI IIL E—fUT|CRRUTEWVET.

  37. Slide 37: NAGASEの強み

    > HAFTEUSsICHI SER MERIDA REO BE TATICUT1ERRERRODRICHEA VOUPUT 1 ie MCL BR-hIFUADBBREED HVENAZORREBBLAT BHVIEWBZORR C VFUPUF+ERRISRROUE HE +) BRI NEVTUPUT4 Hitiesatizs PISAFI-VOR BE Ainipais PERRIER ME<ts ihe aes OO Nes eee A TIVE GREER APNE =, 4 Ae XQAEI AIT UPTO AE RIL AXNAGASE | Delivering next.

  38. Slide 38: 人と地球のウェルビーイングに貢献するNAGASE

    人と地球のウェルビーイングに 貢献するNAGASE 目標    実績   

  39. Slide 39: 事業戦略

    P MHPCHHHO3 IMBAAT 3 FERT CHO S8 1 IKFIC(E ST SBSEA OEE ABA. ATID. PUVA, SUCKREBSITSAMOUILEBAAE CMB OELET RRR (ACE 2.0) OPER GURAHE One NAGASECI=—29AAO EK iN ASTRA ROBE KS M&A@SALER—hI4ZUA DMFT PX Ee BORAT {HOAMDRE TOXIN AR GHEROMEOEDDI 4 N—VF1 OE ee SAWREOIER ABST HSE e@ J—mRL-FKANFVAOREt © MEICHET

  40. Slide 40: ライフサイエンス領域

    PREIROSAT QUEST > LIXUMAHIOZE BS R-bIFUAOHRM CA BNIC. SRAXVKESLAIXUEA BHR CHUCLUREDADBA ADAIR S CSCC C, ROICEBHCLERS &WRL, BARES BRL EN EISA ORR FY25 Boa Flat | bese GF mA 936m | ZAUPIF4 TSAI | naenaneecen mone 767 | EEUF4YUa—Yaye ELUF4 3784 | TVArO=IAz BF rae— || 1488 ——— | STI &ANAT PEL +e 986 AXN

  41. Slide 41: ライフ領域の戦略

    RX predic (7p) Ean EMBO RT > LAXUKG BES BeIXVACeIXVA REAL, BECOMES BBREOMELERY, Sth BAUR CED Le MR EET URE ES HET 20283 “LUPMR—-hIAUADABA a5 tar = EACFBICES HEB SS1F IY OPER 235f8M4 MARR 7) —BLEFER (I-91) ERE Pr seit YATHEUT+1(CHMRT SBRORMIL HEARS ILM OE BERETIGRE EBITDA Be - MBMOWSLTC HR COREL 2168

  42. Slide 42: 事業投資の方針

    PM EREKEROSE{T RENOROE > mRRIRB(ACE 2.0) ORR ACE 2.0) 55tHIL CE EMRIRA (HER) SHRICHIT S CCRC, RAMRORAILEMS CE CHE AVR ME LeSRLEST BEBIULOSS HR-hIAUADAS 4U¥INR—NBRE AtBRORE WELDER HPRICMIS EDAD mi 28-8: 70008 REFER: 10000 m SFM: 20085 MSE (SERRE TIA IC EARICARS MEK Hl MOFSLRSESEO RISE =\)> B19 BROW W

  43. Slide 43: SAP

    バイオ 生分解 次世代 抗酸化 スティミュラント SAP 冷却技術 アミノ酸 生体反応 センサー 低糖化 技術 健康寿命延伸 脱炭素社会 資源循環社会 サプライチェーンの持続性 商社 製造 研究 ネットワーク マッチング力 × 有機合成 機能性糖質 × バイオ AIロボティクス 情報力・現場力 診断薬 など

  44. Slide 44: ケーススタディ

    (238A) Pp I=—-I7AAZORIGI EBRORAT ( RAGREEESO) —) ( seaeeRHEOaH—UIIVS>) ») sta: 5008R~ ER: US CHOOOKERRICLSREMRAABEL BABAR : BHRRLEEDBSAPERALERR ACSC DS BME SD RARE IT BEI UL. SAF. El FERREVAC ABAD SIRB A+ — LEE AXNAGASE | Delivering next. atee:45065~ BRA | WHORE LOBRAPOMBRESCO eRe mSPRR : DRENST OMR

  45. Slide 45: ROE目標

    RRR OST _ aemeet > RENREAOHMO-KVYT IMAMED BIL IROL, SADA LV ALI XVNCBARE BRED L, IREMBEO NSU ALE EDK WAT CIX—PRA ABIL, RUE OUACROEOE_LEBL C HMMA KLALCOR FMW VY AS ORBAEEDES FI LMMBOHB 86789 2,296 1,876 = 63% 1,146 E> 55% - = & 20 25 28 FREBBIR ES ROE 5.9% ROE 8.0% ROE 9.0% ROE 10.0%~ AXNAGASE | Deli

  46. Slide 46: Ox戦略

    Ox OBR > MOAR BUDIRABE CILIR<, AS ORG CH<KIUSICEMNAGASEORITAORR CT OX lERBEOREBACUBEIIT, MOA ZAMCL, TNERDS CE CHMOMRASIARL TNSESF TO IORR ( BiloEReEaenETHETSy FOVIPbLVIAP : EMRERERAL, Ge ee HED SERECEWBE TA SIOL C BREBEAH CUESH ) C (HOA REA BAIEL, HEDASIE HTH ») EDVDARA-TARL—-4— FI -SSRERL eBesIeL,

  47. Slide 47: 経営指標

    aReDt ONES > BAMBHOIER(ROICHEORL) seam TRSAICIES AIOMHM SBAMRESIS LIT, HHI CRSA LLES Soe Flanss Ot Sob) ARZOML ARSc E38 (Oot 5b) BBs (OT oo Le Fae) ROICOMm_E eR AER OM FEL) x1 les )_E 2X1 PLBPIO MER EPR EE ES (OM scl) x2 2 SSSePIOMeH A AXNAGASE | Delivering next. A7 ROBHO, BME ORR GEBET 0 BAMBEOERCL

  48. Slide 48: 投資計画

    SSEDE ORR > BAMBHEOIER(Fryy1vO7—-Yay) RRRARAOTHSIED BAEMRIRVUAITEST HD CAREABL, ROICSLO EPSOMLEICDAITET 2023~20255E 2026~20284E (S40: 83) (884i: 8F3) M&A 2,000 2,000 BRITE ace AFAR M&A Bort S8eeyyago- Be4ryy170— 0 Eze AXNAGASE | Delivering next. 48 C55RFvy Var OT—YalcBugys. BRAN OTHMISS REED, BASMRI

  49. Slide 49: 株主還元方針

    ape tO > I-KRL—-KANFUAOARME = BLAME ANCA MRO SET SMe BHASEE L HHMS MUcRRA OAR & SEAT ES Ree BEILL. I-—ML FANS VASEMELEST BLS WR SORMEO FL (RRR OER] TRILAL A SLC OME [AL ATA ORRBBRCEBRREO IE -SEREOTER [RS Owe) EAH SE -HEMORRC BOL AXNAGASE | Delivering next. 49 I-MRL-FANFVADRMEICRUV ET. BI BRMMEANAL T

  50. Slide 50: 飛躍的成長に向けてEPSを段階的に向上

    飛躍的成⾧に向けてEPSを段階的に向上 総還元性向 100%

  51. Slide 51: 全社KGI

    > Walk the Talk 2028 4=##2 mw 2¢tKGI a =KPI Se Rlee EBITDA 500@rmt BBA, CI XDA CRE ROE ROIC 9.0%mE FHBt, LI XDA TRE Scope, 2HEH EAU Ra (2021 Btt) 32.7% XABRIL, SBTREERS AYO 20305 BRCES AXNAGASE | Delivering next. 51 RRICSUETH Walk the Talk 2028O#2BHRRC LAU TIL, SH KGIOMBBRCL CT. BRAS 5 OOfRFUAL, ROE

  52. Slide 52: 経営理念

    社会の構成員たることを自覚し、 誠実に正道を歩む活動により、 社会が求める製品とサービスを提供し、 会社の発展を通じて、 社員の福祉の向上と社会への貢献に努める

  53. Slide 53: https://www.nagase.co.jp/ir/ https://www.nagase.co.jp/contact/

    https://www.nagase.co.jp/ir/ https://www.nagase.co.jp/contact/

  54. Slide 54: BAIA PGS Bak LERESORSRICMISE MG

    BAIA PGS Bak LERESORSRICMISE MG FRB A ER (RHMASEA 1 IEF) OP HRRIROE MORE O<Y ~TWalk the Talk 2028) [C23 < (iia EAK-—U—~ ACE 2.0 KGI Bae Flas: 4478 ROE: 8% PBR: 1888 AXNAGASE | Delivering next. Walk the Talk 2028 KGI SSeFlae: 500 FLLE ROE: eo) 7a) ae EPS: 30% © 202 RENKRERE ST SI 3 DORA 1, RRR ORT @

  55. Slide 55: 主要指標推移

    SRO ES 202078 202158 20225 202348 20244 Bo 20254 Moss | 5.0% | [7.7% | [6.6% ] [5.0% |] [64% | te [ 8.0% | WMOm (4.2% | [5.3% ] [44% ] [4.0% ] [44% ] QE [5.5% ] MNS [5.7% | [55% | [5.7% ] [50% ] [59% ] 22> [o2x | [0.23%] [0.33%] [ose] [o27e] [o27e | 22° [3.384] [3550] [3.783] [4.013 | [4.064 ] ~22>

  56. Slide 56: ESG評価

    ERE HMREID 5S OSES 2019 202058 20218 202258 202358 202458 202558 FTSE 5.0 1.2 1.9 2.7 3.5 4.2 4.2 4.2 MSCI AAA BB BB BBB A A A AA Climate - - - Change A Cc B B A A A A Cc Water A Cc A- A A A A E Forest A C- Cc Cc B B B B Supply ” A A A A Chain A _ _ _ , Emeeeennannii (J-9—) | (U-Y—-) | (U-¥—-) | (U-

  57. Slide 57: 投資実績

    2021 ~2025FEOEEREVYVIIU PUREE (esti: fa) Fyyyaty 2021 2022K 20235 20245 20255 SHER Ey YI-PIR 2021 20228 20235 20245 20255I SHERI meieeetecr* 525 363 «476 «= 515. 521 2,401 YY EAR 124 139° «#178 «9270 = 331—«*1,044 BERBER GICLSRA 92 96 71 35 50 346 DX: HAMRSAORA 71 68 78 69 71 359 BEAAORY _ _ 330 _ 2

  58. Slide 58: Prinova

    Prinova7/L—-FOS#BRz= eS suas. 7 Nutrition [) |aReeene- 2000RBULOR DUSYIZSEBU, PERN S sent SOMBRE =a-Wyay BRS oe a— SRERMEMOA BSETIVALYT | | FSRMEILTN— fai] | Bsa eta RUSS TARO pt. MBo—Zle Cava ve etet ffi ORE HBC TRE aptyva—yay (PV-FARBEO #48 ele ‘mniti!) () | sl (EER) (2705) (2725) (PIU7—y3 Gl] = B

Nagase & — FY2025 Earnings Presentation on 6ix